Administration of bezafibrate every three days in mice triggered the release of sufficient GM‐CSF and tumor antigens or PD‐L1 nb, effectively repressing tumor growth and inducing upregulation of anti‐tumor immune cells in the blood, dLN, and tumor, respectively. This evidence concerns the gene CD274 and neoplasm.